(Total Views: 370)
Posted On: 02/24/2021 6:08:30 PM
Post# of 145247
![](/m/assets/46931549/no_avatar_available_thumb.jpg)
Re: Borel Fields #79748
From bamlanivimab's phase 3 trial -
Quote:
Ongoing, but accrual of patients receiving bamlanivimab stopped due to lack of benefit
![](/m/images/thumb-up.png)
![](/m/images/thumb-down.png)